Hiemke C - Search Results

1

Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.

Schoretsanitis G, Baumann P, Conca A, Dietmaier O, Giupponi G, Gründer G, Hahn M, Hart X, Havemann-Reinecke U, Hefner G, Kuzin M, Mössner R, Piacentino D, Steimer W, Zernig G, Hiemke C. Schoretsanitis G, et al. Among authors: hiemke c. Ther Drug Monit. 2021 Feb 1;43(1):79-102. doi: 10.1097/FTD.0000000000000830. Ther Drug Monit. 2021. PMID: 33196621 Review.

2

The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.

Gründer G, Wetzel H, Hillert A, Jochum E, Hiemke C, Benkert O. Gründer G, et al. Among authors: hiemke c. Psychopharmacology (Berl). 1995 Feb;117(4):472-8. doi: 10.1007/BF02246221. Psychopharmacology (Berl). 1995. PMID: 7604150

3

Automated determination of paroxetine and its main metabolite by column switching and on-line high-performance liquid chromatography.

Härtter S, Hermes B, Szegedi A, Hiemke C. Härtter S, et al. Among authors: hiemke c. Ther Drug Monit. 1994 Aug;16(4):400-6. doi: 10.1097/00007691-199408000-00011. Ther Drug Monit. 1994. PMID: 7974631

4

Automated determination of clozapine and major metabolites in serum and urine.

Weigmann H, Bierbrauer J, Härtter S, Hiemke C. Weigmann H, et al. Among authors: hiemke c. Ther Drug Monit. 1997 Aug;19(4):480-8. doi: 10.1097/00007691-199708000-00020. Ther Drug Monit. 1997. PMID: 9263393

5

Nonlinear pharmacokinetics of fluvoxamine and gender differences.

Härtter S, Wetzel H, Hammes E, Torkzadeh M, Hiemke C. Härtter S, et al. Among authors: hiemke c. Ther Drug Monit. 1998 Aug;20(4):446-9. doi: 10.1097/00007691-199808000-00016. Ther Drug Monit. 1998. PMID: 9712472

6

Neuroendocrine response to antipsychotics: effects of drug type and gender.

Gründer G, Wetzel H, Schlösser R, Anghelescu I, Hillert A, Lange K, Hiemke C, Benkert O. Gründer G, et al. Among authors: hiemke c. Biol Psychiatry. 1999 Jan 1;45(1):89-97. doi: 10.1016/s0006-3223(98)00125-5. Biol Psychiatry. 1999. PMID: 9894580 Clinical Trial.

7

Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service.

Weigmann H, Gerek S, Zeisig A, Müller M, Härtter S, Hiemke C. Weigmann H, et al. Among authors: hiemke c. Ther Drug Monit. 2001 Aug;23(4):410-3. doi: 10.1097/00007691-200108000-00015. Ther Drug Monit. 2001. PMID: 11477325

8

[Olanzapine: pharmacology, pharmacokinetics and therapeutic drug monitoring].

Rao ML, Hiemke C, Grasmäder K, Baumann P; TDM Arbeitsgruppe Der AGNP. Rao ML, et al. Among authors: hiemke c. Fortschr Neurol Psychiatr. 2001 Nov;69(11):510-7. doi: 10.1055/s-2001-18381. Fortschr Neurol Psychiatr. 2001. PMID: 11704898 Review. German.

9

[Olanzapine: pharmacology, pharmacokinetics and therapeutic drug monitoring].

Rao TA, Hiemke C, Grasmäder K, Baumann P. Rao TA, et al. Among authors: hiemke c. Fortschr Neurol Psychiatr. 2001 Dec;69(12):580-2. doi: 10.1055/s-2001-19184. Fortschr Neurol Psychiatr. 2001. PMID: 11753746 German. No abstract available.

10

New dopamine D2 receptor polymorphisms in rats and association with apomorphine-induced stereotypies.

Germeyer S, Birke A, Schmitt U, Dahmen N, Hiemke C, Havemann-Reinecke U. Germeyer S, et al. Among authors: hiemke c. Brain Res. 2002 Feb 1;926(1-2):1-9. doi: 10.1016/s0006-8993(01)03136-5. Brain Res. 2002. PMID: 11814400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters